Recordati (REC.MI)

Quick facts

Marketed products

• Carbaglu · Gastroenterology · revenue 200
  Carbaglu works by activating the enzyme carbamoyl phosphate synthetase 1, which helps regulate ammonia levels in the body.
• Isturisa · Respiratory · revenue 200
  Isturisa blocks the production of cortisol in the adrenal glands by inhibiting the cytochrome P450 11B2 enzyme.
• Cystadane · Infectious Disease
• Cosmegen · Oncology
  Dactinomycin binds DNA and inhibits RNA synthesis, demonstrating cytotoxic activity in cancer models.
• Peganone · Neuroscience
• Valchlor · Oncology
  Valchlor works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death.
• Signifor · Oncology
  Signifor works by binding to somatostatin receptors on the surface of cells, mimicking the natural hormone somatostatin to reduce cortisol production.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Recordati portfolio CI brief
• Recordati pipeline updates RSS